AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 192 filers reported holding AGIOS PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 1.15 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $565,361 | +58.8% | 24,613 | +257.0% | 0.02% | -51.5% |
| Q1 2021 | $356,000 | -12.5% | 6,894 | -40.7% | 0.03% | +26.9% |
| Q3 2020 | $407,000 | -21.9% | 11,622 | +19.4% | 0.03% | -27.8% |
| Q2 2020 | $521,000 | -22.6% | 9,737 | -48.6% | 0.04% | -26.5% |
| Q1 2020 | $673,000 | -36.1% | 18,960 | -10.3% | 0.05% | -48.4% |
| Q2 2019 | $1,054,000 | +30.0% | 21,138 | +20.2% | 0.10% | +86.3% |
| Q4 2018 | $811,000 | +284.4% | 17,584 | +376.5% | 0.05% | +121.7% |
| Q4 2017 | $211,000 | – | 3,690 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Rock Springs Capital Management LP | 2,661,605 | $61,137,067 | 1.46% |
| Bellevue Group AG | 4,013,500 | $92,190,095 | 1.34% |
| Eagle Health Investments LP | 267,630 | $6,147,461 | 1.20% |
| ARMISTICE CAPITAL, LLC | 3,460,000 | $79,476,200 | 1.14% |
| Integral Health Asset Management, LLC | 213,000 | $4,892,610 | 0.99% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 454,000 | $10,428,380 | 0.44% |
| ArrowMark Colorado Holdings LLC | 1,557,705 | $35,780,484 | 0.41% |
| FARALLON CAPITAL MANAGEMENT LLC | 2,092,829 | $48,072,282 | 0.27% |
| Virtus ETF Advisers LLC | 9,932 | $228,138 | 0.13% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 614,533 | $14,115,823 | 0.09% |